- Trials with a EudraCT protocol (119)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
119 result(s) found for: Basdai.
Displaying page 1 of 6.
EudraCT Number: 2015-001106-33 | Sponsor Protocol Number: CAIN457H2315 | Start Date*: 2016-02-01 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled multicenter study of secukinumab 150 mg in patients with active non-radiographic axial spondyloarthritis to evaluate the safety, tolerability and effi... | |||||||||||||
Medical condition: non-radiographic axial spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) ES (Completed) NL (Completed) HU (Completed) PT (Completed) NO (Completed) SE (Completed) BE (Completed) BG (Completed) FR (Completed) CZ (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-020913-10 | Sponsor Protocol Number: ANS/4.3 | Start Date*: 2010-08-11 |
Sponsor Name:Norfolk & Norwich University Hospitals NHS Foundation Trust | ||
Full Title: An open label, pilot, multi-centre, step-down, randomised controlled trial to examine whether Etanercept 25mg once weekly is effective in maintaining a clinical response in patients with Ankylosing... | ||
Medical condition: Ankylosing spondylitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002306-64 | Sponsor Protocol Number: Ritux-AS-01 | Start Date*: 2006-12-28 |
Sponsor Name:Charité Universitaetsmedizin | ||
Full Title: Open label clinical trial with Rituximab (MabThera ®) in Ankylosing Spondylitis - Extension of open label trial: Re-Treatment of patients who have shown response to first course of Rituximab | ||
Medical condition: Moderate to severe ankylosing spondylitis who have had an inadequate response to or do not tolerate conventional therapy including NSAIDs, DMARDs and TNF alpha inhibitors | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-003666-13 | Sponsor Protocol Number: 1311.8 | Start Date*: 2013-12-26 | |||||||||||
Sponsor Name:Boehringer Ingelheim España, S.A. | |||||||||||||
Full Title: A 48 weeks, phase II, randomized, double-blind, placebo-controlled, proof of concept and dose finding study of three different dose regimens of BI 655066 administered subcutaneously in patients wit... | |||||||||||||
Medical condition: Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) FI (Completed) DE (Completed) IT (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005398-18 | Sponsor Protocol Number: W15-679 | Start Date*: 2016-07-12 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: Treating patients with early axial spondyloarthritis to target – a 1 year randomized controlled study taking an intense treatment approach versus routine treatment (STRIKE) | |||||||||||||
Medical condition: Axial spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004575-74 | Sponsor Protocol Number: CAIN457FDE03 | Start Date*: 2016-03-16 | |||||||||||
Sponsor Name:Novartis Pharma GmbH | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled multicenter study of Secukinumab (AIN457) to examine the clinical efficacy and the NSAID-sparing effect of Secukinumab over 16 weeks in patients with ... | |||||||||||||
Medical condition: Ankylosing Spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001177-90 | Sponsor Protocol Number: CAIN457P12301 | Start Date*: 2020-01-21 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group, phase III multicenter study of intravenous secukinumab to compare efficacy at 16 weeks with placebo and to assess safety and tolera... | |||||||||||||
Medical condition: Axial Spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GR (Completed) SE (Completed) CZ (Completed) BG (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019872-65 | Sponsor Protocol Number: MK-0663-108 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase III, Two-Part, Randomized, Double-Blind, Active Comparator-Controlled, Multicenter Clinical Trial to Study the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patie... | |||||||||||||
Medical condition: Ankylosing Spondylitis (AS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) FI (Completed) BE (Completed) AT (Completed) GB (Completed) EE (Completed) SK (Completed) CZ (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000288-16 | Sponsor Protocol Number: CNTO1275AKS3002 | Start Date*: 2015-08-18 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Refractory Subjects With Active Radiogra... | |||||||||||||
Medical condition: Axial Spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Prematurely Ended) ES (Prematurely Ended) CZ (Prematurely Ended) BE (Completed) PL (Completed) BG (Prematurely Ended) GB (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003636-21 | Sponsor Protocol Number: GLPG0634-CL-223 | Start Date*: 2017-01-26 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, multicenter, Phase II study to assess the efficacy and safety of filgotinib administered for 12 weeks to subjects with active ankylosing spondylitis | |||||||||||||
Medical condition: ankylosing spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) CZ (Completed) ES (Completed) BG (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000343-14 | Sponsor Protocol Number: AS0007 | Start Date*: 2017-01-04 | |||||||||||
Sponsor Name:UCB Biopharma SPRL. | |||||||||||||
Full Title: Multicenter, Open-Label Study To Assess The Effects Of Certolizumab Pegol On The Reduction Of Anterior Uveitis Flares In Axial Spondyloarthritis Subjects With A History Of Anterior Uveitis (C-VIEW) | |||||||||||||
Medical condition: Anterior Uveitis in subjects with Axial Spondyloarthritis (axSpA) and a history of AU. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) CZ (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001694-28 | Sponsor Protocol Number: Version 1 | Start Date*: 2007-05-10 |
Sponsor Name:Department of Rheumatology, Hvidovre Hospital | ||
Full Title: SPARTA – spondyloarthritis remission trial after adalimumab | ||
Medical condition: Spondyloarthropaties and ankylosing spondyllitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000289-67 | Sponsor Protocol Number: CNTO1275AKS3003 | Start Date*: 2015-06-22 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Subjects With Active Nonradiographic Axial Spondyloa... | |||||||||||||
Medical condition: Nonradiographic Axial Spondylitis, Ankylosing | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) HU (Completed) DE (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000814-31 | Sponsor Protocol Number: CAIN457F3302 | Start Date*: 2016-08-03 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: MAXIMISE (Managing AXIal Manifestations in Psoriatic Arthritis with SEcukinumab), a randomized, double-blind, placebo-controlled, multicenter, 52 week study to assess the efficacy and safety of sec... | |||||||||||||
Medical condition: Axial Psoriatic Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) FR (Completed) GB (Completed) HU (Completed) EE (Completed) IE (Completed) BE (Completed) FI (Completed) DK (Prematurely Ended) DE (Completed) BG (Completed) GR (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000646-35 | Sponsor Protocol Number: M13-375 | Start Date*: 2013-07-08 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects with Non Radiographic Axial... | |||||||||||||
Medical condition: Axial Spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) SK (Completed) IT (Completed) FI (Completed) DE (Completed) CZ (Completed) DK (Completed) SE (Completed) GB (Completed) IE (Completed) NL (Completed) NO (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002349-35 | Sponsor Protocol Number: 0881A3-102090 | Start Date*: 2006-09-30 |
Sponsor Name:Wyeth Farma S.A. | ||
Full Title: Estudio piloto randomizado, doble ciego, multicéntrico a 12 semanas para evaluar el efecto de etanercept 100mg y 50mg semanales en sujetos con espondilitis anquilosante. A 12-week randomized, do... | ||
Medical condition: Espondilitis anquilosante Ankylosing spondylitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-000465-32 | Sponsor Protocol Number: CNTO1959PSA4002 | Start Date*: 2021-08-11 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants with Active Psoriat... | |||||||||||||
Medical condition: Active Psoriatic Arthritis Axial Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) ES (Ongoing) PL (Ongoing) DE (Ongoing) HU (Ongoing) PT (Trial now transitioned) IT (Ongoing) BG (Ongoing) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002748-27 | Sponsor Protocol Number: 0881A3-403 | Start Date*: 2007-04-13 | |||||||||||
Sponsor Name:Wyeth Pharmaceuticals France | |||||||||||||
Full Title: A Multicentre, Double-Blind, Placebo-Controlled, Randomised Study of Etanercept in the Treatment of Adult Patients with Active, Severe and Advanced Axial Ankylosing Spondylitis | |||||||||||||
Medical condition: Active, severe and advanced axial ankylosing spondylitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) FR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000311-34 | Sponsor Protocol Number: P07642 | Start Date*: 2011-11-29 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effect of Golimumab Administered Subcutaneously in Subjects with Active Axial Spondyloarthritis (Phase 3b, Protocol No. P0... | |||||||||||||
Medical condition: Active Axial Spondyloarthritis (SpA) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) FI (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000401-21 | Sponsor Protocol Number: CAIN457H3301 | Start Date*: 2017-05-16 | |||||||||||
Sponsor Name:Novartis Farmacéutica, S.A. | |||||||||||||
Full Title: SKIPPAIN (Speed of onset of SecuKinumab-Induced relief from Pain in Patients with Axial SpoNdyloarthritis) A 24-week, randomized, double-blind, placebo-controlled, multicenter study to evaluate the... | |||||||||||||
Medical condition: Axial Spondyloarthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) FI (Completed) GB (Completed) LV (Completed) LT (Completed) GR (Completed) BE (Completed) SE (Completed) BG (Completed) PL (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.